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Introduction. Cell therapy using stem cells is a promising strategy for the treatment of ischemic 
diseases, nevertheless low viability of implanted cells, is one of the main problems limiting stem cell 
therapy. In addition, there is a risk of proliferation of the transformed cells in mesenchymal stem cells 
carrying properties of cancer stem cells. Using conditioned media from stem cells instead of stem cell 
themselves avoids the risks that may arise with the direct use of stem cells. Conditioned media from 
various stem cells contains a different number of cytokines and growth factors, necessary for the natural 
process of new vessel formation. 
Methodology. The objective of current proposal is to fabricate biodegradable polymer based 
micro- and nanoparticles containing growth factors secreted by human amniotic membrane derived 
mesenchymal stem cells for induction of angiogenesis. When injected, produced nanostructures will 
degrade and gradually release growth factors into ischemic environment of tissue. We hypothesize that 
this time-dependent and prolonged release of growth factors will facilitate and improve development of 
collaterals, thus restoring blood flow into ischemic tissue. We believe that this method, rather than direct 
administration of stem cells, would bypass critical clinical issues, such as potential tumorigenesis and the 
graft versus host incompatibility that occurs in allogeneic transplantations. 
Results and discussion. The effectiveness of angiogenesis induction by growth factors secreted by 
various types of stem cells was shown in in vitro experiments using endothelial cells of human umbilical 
vein and in vivo experiments using mice. Experiments were performed to encapsulate the growth factors 
into biodegradable polymer using two methods: electrospray and double emulsion. The size of the 
prepared capsules was from 500 nm to 20 microns.The biodegradable polymer, PLGA, was used for 
this study. Electrospray was performed on Electrospinner brand Yflow. The encapsulation efficiency was 
checked by UV spectrometer. The size distribution was calculated using Zetasizer. Morphology of the 
capsules was determined by atomic force microscope. 
Conclusions. In vitro and in vivo experiments using animal model show that conditioned media 
of multipotent stem cells contains cocktail of growth factors which are able at certain degree induce 
formation of blood vessels. This property of stem cell conditioned media further could be facilitated to 
develop cell-free technology for inducing angiogenesis suitable for clinical application. 
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